Skip to main content

Table 1 Patient demographics

From: Voxel-level biological optimisation of prostate IMRT using patient-specific tumour location and clonogen density derived from mpMRI

Patient number

Age (years)

PSA (ng/mL)

Gleason score of the dominant nodule

Pathological stage

1

59

16

7 (4 + 3)

pT3a

2

68

27

9 (5 + 4)

pT3b N0

3

68

10.5

7 (4 + 3)

pT3a

4

71

10

7 (3 + 4)

pT2c

5

63

11

7 (4 + 3)

pT3a